Healthy Skepticism Library item: 4657

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

World Health Organization
FDA acts against misleading marketing of osalazine
Essential Drugs Monitor 1993; (16):3

Abstract:

The United States Food and Drug Administration has announced that Kabi Pharmacia will be required to undertake an extensive campaign to correct misleading promotion and advertising for its ulcerative colitis drug osalazine.

Keywords:
*news story/United States/regulation of promotion/FDA/Food and Drug Administration/Kabi Pharmacia/REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION